Accessibility Menu
 
Poolbeg Pharma Plc logo

Poolbeg Pharma Plc

(LSE) POLB

Current Price$5.04
Market Cap$3.55B
Since IPO (2021)-53%
5 YearN/A
1 Year+98%
1 Month+10%

Poolbeg Pharma Plc Financials at a Glance

Market Cap

$3.55B

Revenue (TTM)

$0.00

Net Income (TTM)

$11.48M

EPS (TTM)

$-0.93

P/E Ratio

-5.42

Dividend

$0.00

Beta (Volatility)

-0.05 (Low)

Price

$5.04

Volume

170,991

Open

$4.70

Previous Close

$5.04

Daily Range

$4.70 - $5.04

52-Week Range

$2.40 - $5.20

POLB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Poolbeg Pharma Plc

Industry

Pharmaceuticals

CEO

Jeremy Skillington, PhD

Headquarters

London, E1 2AX, GB

POLB Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-64%

Return on Capital

-75%

Return on Assets

-57%

Earnings Yield

-18.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.55B

Shares Outstanding

705.10M

Volume

170.99K

Avg. Volume

908.10K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$6.42M

EBITDA

$6.42M

Operating Cash Flow

$4.51M

Capital Expenditure

$4.51M

Free Cash Flow

$0.00

Cash & ST Invst.

$7.71M

Total Debt

$0.00

Poolbeg Pharma Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$3.55B

N/A

Market Cap/Employee

$236.91M

N/A

Employees

15

N/A

Net Income

$3.52M

-65.9%

EBITDA

$3.86M

-44.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$7.71M

-36.6%

Accounts Receivable

$555.00K

-20.7%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-57.28%

N/A

Return on Invested Capital

-74.62%

N/A

Free Cash Flow

$0.00

+100.0%

Operating Cash Flow

$2.16M

-17.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HEMO.LHemogenyx Pharmaceuticals Plc
$690.00+1.47%
NCYT.LNovacyt S.A.
$48.50-3.00%
SAR.LSareum Holdings plc
$20.50-2.38%
FAB.LFusion Antibodies plc
$12.75-3.77%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$15.47+0.09%
FFord Motor Company
$14.93+0.09%
AALAmerican Airlines Group
$13.85+0.02%
NIONio
$5.20-0.07%

Questions About POLB

What is the current price of Poolbeg Pharma Plc?

Poolbeg Pharma Plc is trading at GBX 5.04 per share.

What is the 52-week range for Poolbeg Pharma Plc?

Over the past 52 weeks, Poolbeg Pharma Plc has traded between GBX 2.40 and GBX 5.20.

How much debt does Poolbeg Pharma Plc have?

As of the most recent reporting period, Poolbeg Pharma Plc reported total debt of N/A.

How much cash does Poolbeg Pharma Plc have on hand?

Poolbeg Pharma Plc reported $7.71M in cash and cash equivalents in its most recent financial results.

What is Poolbeg Pharma Plc’s dividend yield?

Poolbeg Pharma Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.